The elderly population is at risk for polypharmacy and, therefore, also at risk for drug-induced osteoporosis (DIOP). Epidemiologic studies provide valuable information about medications that may ...
Bisphosphonates are currently the medication of choice for both prevention and treatment of glucocorticoid-induced osteoporosis. Teriparatide has been shown to be better than alendronate and might ...
Eladynos – which is only the second osteoporosis drug to reach UK patients in the last 15 years – could now find a role as an alternative to Evenity and Forsteo, is seen as an important ...
Two Key Genes Identified Linking Rheumatoid Arthritis and Osteoporosis Nov. 5, 2024 — Researchers employed analysis tools and machine learning algorithms to identify two genes linked to ...
Amgen’s osteoporosis bone-forming drug Evenity (romosozumab) has been approved in Japan, ahead of a crunch review by advisers to the US regulator later this month. Evenity could have been on the ...